trimetazidine has been researched along with Hypertrophy, Right Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, SL; Bache-Wiig, P; Fang, YH; Hong, Z; Marsboom, G; Piao, L; Rehman, J; Toth, PT | 1 |
| Guarnieri, C; Muscari, C | 1 |
2 other study(ies) available for trimetazidine and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Topics: Acetanilides; Animals; Enzyme Inhibitors; Fatty Acids; Glucose Transporter Type 1; Glycogen; Glycolysis; Hexokinase; Hypertrophy, Right Ventricular; Male; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents; Ventricular Function, Right | 2012 |
Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium.
Topics: Animals; Hypertrophy, Right Ventricular; Male; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Trimetazidine | 1993 |